erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
Dual effects of erastin on aggressive osteosarcoma cells: ferroptosis sensitization and anti-ferroptotic gene activation. (PubMed, Cytotechnology) - Jun 26, 2025 - "Targeting this anti-ferroptotic differential gene expression mediated by erastin-induced ferroptosis in OS cells may help to improve erastin's efficacy. The online version contains supplementary material available at 10.1007/s10616-025-00795-7." 
Journal • Oncology • Osteosarcoma • Sarcoma • Solid Tumor • HMOX1 • SLC3A2 • SLC7A11
http://www.ncbi.nlm.nih.gov/pubmed/40567388
 
Gordon Daniel Burns; Kevin Schneider; M Cristina Kenney; Marilyn Chwa; Mithalesh Kumar Singh; Shari Atilano; Steven Chang
 
Jun 26, 2025
 
Prev Next